DGAT2 Inhibition Potentiates Lipid Droplet Formation To Reduce Cytotoxicity in APOL1 Kidney Risk Variants.
Justin ChunCristian V RiellaHyunjae ChungShrijal S ShahMinxian WangJose M MagranerGuilherme T RibasHennrique T RibasJia-Yue ZhangSeth L AlperDavid J FriedmanMartin R PollakPublished in: Journal of the American Society of Nephrology : JASN (2022)
Lipogenesis and lipid droplet formation are important modulators of APOL1-associated cytotoxicity. Inhibition of DGAT2 may offer a potential therapeutic strategy to attenuate cytotoxic effects of APOL1 risk variants.